Dose and secondary cancer-risk estimation of patients undergoing high dose rate intracavitary gynaecological brachytherapy

被引：1
|
作者：
Doudoo, Chris Osam [1 ,2 ]
Gyekye, Prince Kwabena [2 ]
Emi-Reynolds, Geoffrey [2 ]
Adu, Simon [2 ]
Kpeglo, David Okoh [2 ]
Tagoe, Samuel Nii Adu [3 ]
Agyiri, Kofi [3 ]
机构：
[1] Sweden Ghana Med Ctr, POB MD 1879, Accra, Ghana
[2] Univ Ghana, Sch Nucl & Allied Sci, POB AE 1, Accra, Ghana
[3] Natl Ctr Radiotherapy & Nucl Med, Korle Bu, Accra, Ghana
来源：
JOURNAL OF MEDICAL IMAGING AND RADIATION SCIENCES | 2023年 / 54卷 / 02期
关键词：
ALARA; Dose optimisation; Electronic dosimeters; Organ doses; Radiotherapy; RADIATION-INDUCED CANCER; BODY-MASS INDEX; 2ND CANCERS; RADIOTHERAPY; SURVIVORS; PROSTATE; THERAPY; ORGANS;
D O I：
10.1016/j.jmir.2023.03.031
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
Dose and secondary cancer risk of the breast and thyroid during high dose rate (HDR) brachytherapy for 100 gynaecological cancer patients have been estimated. The organ doses were measured using LiF thermoluminescence dosimeters LiF (TLD-100). Patient demographic data (i.e. age and body mass index (BMI)) were also collected observed for the correlation between age and breast dose; body mass index (BMI) and breast dose as well as BMI and thyroid dose. The average breast dose for cervical, vaginal and endometrial cancers were 7.44, 8.03 and 10.72 mGy, respectively. The average thyroid dose for cervical, vaginal and endometrial cancers were 2.32, 2.95 and 3.02 mGy, respectively. Excess absolute risk of the breast increased with atat exposure. It is recommended to intensify post-treatment follow-ups and optimize the doses to the breast and thyroid.
引用
收藏
页码：335 / 342
页数：8
相关论文
共 50 条
  • [41] CT based three dimensional dose-volume evaluations for high-dose rate intracavitary brachytherapy for cervical cancer
    Naoya Murakami
    Takahiro Kasamatsu
    Akihisa Wakita
    Satoshi Nakamura
    Hiroyoki Okamoto
    Koji Inaba
    Madoka Morota
    Yoshinori Ito
    Minako Sumi
    Jun Itami
    BMC Cancer, 14
  • [42] Image-based intracavitary high dose rate (HDR) Brachytherapy for cervical cancer: Organ volume size and dose specification
    Wang, B.
    Zhu, Y.
    Yeo, I.
    Kwon, A. K.
    Henson, C.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2007, 69 (03): : S393 - S394
  • [43] The Meaning and Experience of Patients Undergoing Rectal High-Dose-Rate Brachytherapy
    Perez, Samara
    Neron, Sylvain
    Benc, Renata
    Rosberger, Zeev
    Te Vuong
    CANCER NURSING, 2016, 39 (01) : 42 - 50
  • [44] Cervix cancer brachytherapy: High dose rate
    Miglierini, P.
    Malhaire, J. -P.
    Goasduff, G.
    Miranda, O.
    Pradier, O.
    CANCER RADIOTHERAPIE, 2014, 18 (5-6): : 452 - 457
  • [45] High dose rate brachytherapy for oral cancer
    Yamazaki, Hideya
    Yoshida, Ken
    Yoshioka, Yasuo
    Shimizutani, Kimishige
    Furukawa, Souhei
    Koizumi, Masahiko
    Ogawa, Kazuhiko
    JOURNAL OF RADIATION RESEARCH, 2013, 54 (01) : 1 - 17
  • [46] Predicting Dose-Volume-Histograms for Intracavitary High-Dose-Rate Brachytherapy for Gynecologic Applications
    Guthier, C. V.
    King, M.
    Lee, L. J.
    Cormack, R. A.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2018, 102 (03): : E536 - E536
  • [47] Optimal dose and fractionation for combination external beam radiotherapy and high-dose-rate intracavitary brachytherapy for uterine cervical cancer
    Cho, J. H.
    Kim, H. C.
    Keum, K. C.
    Lee, C. G.
    Lee, I. J.
    Shim, S. J.
    Seong, J.
    Suh, C. O.
    Kim, G. E.
    EJC SUPPLEMENTS, 2005, 3 (02): : 404 - 404
  • [48] High dose rate brachytherapy for prostate cancer
    Hoskin, P.
    CANCER RADIOTHERAPIE, 2008, 12 (6-7): : 512 - 514
  • [49] High-dose rate brachytherapy for high-risk prostate cancer
    Schenck, M.
    Krause, K.
    Schwandtner, R.
    Haase, I.
    Fluehs, D.
    Friedrich, J.
    Jaeger, T.
    Boergermann, C.
    Ruebben, H.
    Stuschke, M.
    UROLOGE, 2006, 45 (06): : 715 - +
  • [50] Efficacy of adjuvant pelvic and high dose rate intracavitary radiation in patients with intermediate to high risk endometrial cancer
    Dunphy, EA
    Petereit, DG
    Schink, JC
    Grosen, EA
    Hartenbach, EM
    Buchler, DA
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1997, 39 (02): : 295 - 295
12345